1 / 32

Gastric Emergencies

Gastric Emergencies. Principles of Critical Care Module Session length 1hour. Contents. Introduction - What is a gastric emergency? Learning objectives for session Oesophageal Varices Pathophysiology Management options Gastric / duodenal Ulcers Pathophysiology Management options

evangeline-byrd
Télécharger la présentation

Gastric Emergencies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Gastric Emergencies Principles of Critical Care Module Session length 1hour

  2. Contents • Introduction - What is a gastric emergency? • Learning objectives for session • Oesophageal Varices • Pathophysiology • Management options • Gastric / duodenal Ulcers • Pathophysiology • Management options • Summary

  3. Introduction This session will focus on the more commonly seen gastric emergencies presenting within critical care settings – • A. Bleeding varices • B. Gastric / Duodenal ulcers The pointecaste will explore the pathophysiology of these types of GI bleed, looking at immediate management options, and the longer term care issues patients with these conditions present to critical care settings. GI bleeds present numerous challenges for critical care with many factors affecting prognosis. Overall mortality from variceal haemorrhage ranges from 30%, reaching 50% in Child’s grade C (Kumar & Clark, 2001).

  4. Objectives • Understand the pathophysiological processes underpinning common gastric emergencies • Identify different treatment options for each gastric emergency and implications for use • Recognise treatment priorities within the critically ill patient using a systematic approach • Understand the longer term implications of common gastric emergencies and management strategies within critical care

  5. A. Oesophageal Varices

  6. Pathophysiology • Portal vein is formed by the union of the superior mesenteric and splenic vein • Internal pressure 5 – 8mmHg with only a small gradient across the liver to the hepatic vein in which the blood is returned to the heart via the inferior vena cava. Oesophageal varices develop when blood through this area is obstructed • Prehepatic - egThrombosis • Intrahepatic – eg Cirrhosis, Hepatitis • Posthepatic – eg Budd-Chiari syndrome • Net result of obstruction is a rise in internal pressure within portal vein

  7. Portal Hypertension As portal pressure rises above 10 – 12mmHg venous system dilates and collaterals occur at the gastro-oesphageal junction, the rectum, left renal vein, the diaphragm etc The collaterals at the gastro-oesophageal junction are superficial in position and tend to rupture

  8. Critical Care Management In emergency situations, the care is directed at, • 1. Stopping haemorrhage • 2. Maintaining plasma volume • 3. Correcting disorders in coagulation induced by cirrhosis • 4. Antibiotic prophylaxis (sepsis / spontaneous bacterial peritonitis)

  9. Sengstaken-Blakemore tube Drugs – Vasopressin, Beta Blockers, Octreotide Endoscopy Variceal ligation, or banding Sclerotherapy Transjugular intrahepatic portosystemic shunt (TIPS) Distal splenorenal shunt procedure Liver transplantation Management options

  10. 1. Stopping the Haemorrhage

  11. Sengstaken-Blakemore Tube • Aim - to tamponade the bleeding varices • Oesophageal/ gastric balloon inflated with up to 60mls, and gastric and oesophageal lumens for drainage • Recommended balloon pressures vary from • 25-40mmHg (McCaffrey, 1991) • 50-60mmHg (Sung 1997) • May require tension for optimal functioning but this is controversial (Woodrow, 2000) Can you think of any potential complications?

  12. What are the potential complications associated with using a Sengstaken-Blakemore tube? Can you think of 5? (Press the pause button while you do this activity)

  13. Other types of tube available • Linton-Nachlas tube, with large gastric balloon, and gastric and oesophageal aspirates • Minnesota four-lumen balloon with oesophageal and gastric balloons, and oesophageal and gastric aspirates. Sengstaken-Blakemore Tube

  14. Potential complications • Oesophageal / gastric rupture • Oesophageal / gastric ischaemia ulceration or necrosis • Extent of subcutaneous bleeding remains unseen • Patient non compliance / discomfort • Risk to airway – Intubation usually required To aid insertion tubes should be chilled – Do you know where they are kept on your unit?

  15. Limitations • Balloon tamponade controls 85 – 92% of bleeds, but rebleeds are common (Boyer & Henderson, 1996) • Balloon tamponade is often used as only a temporary emergency measure – due to complications limit balloon use to 24hrs (Hudak etal, 1998)

  16. Drug treatments Vasopressin / Desmopressin / Terlipressin Antidiurectic hormone causes splanchnic arterial vasoconstriction, thus reducing portal hypertension. Temporarily controls haemorrhage in 28 – 70% of patients (Boyer & henderson, 1996). Cautions – up to one third may rebleed during treatment (Boyer & henderson, 1996). Used as a holding measure until definitive treatment obtained Octreotide (a somatostatin analogue) Causes splanchnic vasoconstriction without significant systemic vascular effects. Reduces splanchnic blood flow and acid secretion Beta-Blockers Also cause splanchnic vasoconstriction, thus reducing portal hypertension in approx 60% of patients with cirrhosis

  17. Endoscopy - Sclerotherapy & Banding • Sclerotherapy – Endoscopic injection of 5% Ethanolamine Oleate (or similar) into varices • Banding – Endoscopic ligatation with bands Arrest bleeding in approx 80% of cases (Kumar & Clark, 2001)

  18. Transjugular Intrahepatic Portosystemic Shunt (TIPS) • Fistula created between the portal and hepatic veins and expandable shunt inserted to maintain patency

  19. 2. Maintaining circulation

  20. Maintaining plasma volume • Close haemodynamic monitoring • CVP monitoring • BP monitoring • Capillary refill times / evidence of compensation? • Patient history • Fluid balance - vomited blood (fresh or altered) / evidence of malaena • Fluid replacement • Blood / clotting products • Plasma expanders eg Voluven or Gelofusion • Crystalloids eg 0.9% Saline

  21. 3. Coagulation Packed red cells Platelets Fresh frozen plasma Cryoprecipitate

  22. Coagulation • Correcting disorders in coagulation induced by cirrhosis • Blood transfusion • Fresh frozen plasma • Platelets • Cryoprecipitate • Vitamin K

  23. B. Gastric / Duodenal ulcers • A bacterial infection - Helicobacter pylori infection • Medication, nonsteroidal anti-inflammatory drugs (NSAIDs) - aspirin, ibuprofen and naproxen • Stress • Diet • Hypersecretory states eg Zollinger-Ellison syndrome

  24. Signs and symptoms • Loss of weight / appetite • Pain, heartburn, or indigestion • Feeling of abdominal fullness or distention • Pain triggered or aggravated by eating 90 mins – 3hrs after eating

  25. Mucosal erosion

  26. Gastric Ulcer • Ulcer crater may extend beyond duodenal wall into nearby structures eg pancreas and liver • Ulcer crater may erode through blood vessels

  27. NSAIDs • Aspirin and other NSAIDs deplete mucosal prostaglandins by inhibiting the cyclooxygenase (COX) pathway – leading to mucosal damage • Cyclooxygenase occurs in two forms • COX I - the constituitive enzyme • COX II - the inducible form which is produced by cytokine stimulation in areas of inflammation (Kumar & Clark, 2001)

  28. Investigations • Endoscopy – direct visualisation • Carbon-13 urea breath test reflects activity of H.pylori • Barium swallow • X Ray • Occult blood in stools • WBC count elevated • Gastric secretory studies – excess hydrochloric acid

  29. Management options • Immediate ABCDE assessment and intervention • Proton pump inhibitor eg Omeprazole, Pantoprazole • H2 receptor antagonists eg Ranitidine • Endoscopy – • injection with adrenaline + sclerosant • vessel coagulated with heat probe or laser therapy • Surgical oversewing or resection of area

  30. ABCDE approach • Airway • Is patient maintaining airway – aspiration risk? • Oxygen / suction / airway adjuncts / elective intubation • Breathing • Respiratory rate / oxygen sats / ABGs • Circulation • Signs of shock – capillary refill time / compensation (peripherally shut down) • Observations – Pulse / BP / CVP / JVP • Early large bore venous access • Bloods – FBC / Clotting / LFTs / U&Es / cross match • Fluid replacement – Blood products / colloid / crystalloids • Fluid balance / input - output • Disability • GCS / AVPU score / Blood sugar • Exposure • Source of bleeding / volume • Patient history • Pain control • Temperature

  31. Exercise Go and read / ask around on this topic and enter you findings on the discussion board Some areas to consider….. • What are the problems associated with using nasogastric tubes in these patients? • When should you allow eating and drinking? • Whether you should use traction on a Sengstaken tube? • What nursing interventions do these patients require?

  32. Summary • GI bleeds can occur from multiple pathologies from cancer to infection. Or can result from the knock on effect of a disease process elsewhere in the body such as oesophageal bleeds as a result of portal hypertension • Management should reflect the severity of the bleed with initial priority aimed at haemorrhage control and fluid management • Longer term management aimed at finding / controlling the cause such as drugs or infection

More Related